Regeneron Bets $100M That Mammoth's CRISPR Tech Can Deliver on Next Wave of Genetic Medicines medcitynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medcitynews.com Daily Mail and Mail on Sunday newspapers.
As the annual J.P. Morgan HealthCare Conference kicked off Monday, two pharma giants unveiled deals that give them access to in-vivo gene editing technologies. Pfizer is teaming up with Beam Therapeutics to develop new base-editing therapies while Bayer hopes to develop new medicines with the in-vivo CRISPR editing tools of Mammoth Biosciences.
The International Space Station (ISS) is backdropped over Miami, Florida. Photo: Wikimedia Commons.
CTech – During an official opening event on behalf of the Israel Space Agency, the Ramon Foundation, and the Ministry of Science and Technology, which took place on Wednesday, second Israeli astronaut Eytan Stibbe revealed which Israeli technologies’ proposals made the cut and will accompany him on his February 2022 mission to the International Space Station. Several leading public and industry figures were in attendance including Inbal Kreiss, head of the Technological Committee which chose the experiments; Chairman of the Ramon Foundation, Ran Livne; Director-General of the ISA Avi Blasberger; and Director General of the Ministry of Science and Technology Shai-Lee Spigelman, among others.